1. Home
  2. EYPT vs GCBC Comparison

EYPT vs GCBC Comparison

Compare EYPT & GCBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EYPT
  • GCBC
  • Stock Information
  • Founded
  • EYPT 1987
  • GCBC 1889
  • Country
  • EYPT United States
  • GCBC United States
  • Employees
  • EYPT N/A
  • GCBC N/A
  • Industry
  • EYPT Biotechnology: Laboratory Analytical Instruments
  • GCBC Banks
  • Sector
  • EYPT Industrials
  • GCBC Finance
  • Exchange
  • EYPT Nasdaq
  • GCBC Nasdaq
  • Market Cap
  • EYPT 489.4M
  • GCBC 452.9M
  • IPO Year
  • EYPT 2005
  • GCBC 1998
  • Fundamental
  • Price
  • EYPT $6.15
  • GCBC $27.19
  • Analyst Decision
  • EYPT Strong Buy
  • GCBC
  • Analyst Count
  • EYPT 8
  • GCBC 0
  • Target Price
  • EYPT $25.71
  • GCBC N/A
  • AVG Volume (30 Days)
  • EYPT 886.1K
  • GCBC 20.6K
  • Earning Date
  • EYPT 03-06-2025
  • GCBC 01-22-2025
  • Dividend Yield
  • EYPT N/A
  • GCBC 1.32%
  • EPS Growth
  • EYPT N/A
  • GCBC N/A
  • EPS
  • EYPT N/A
  • GCBC 1.54
  • Revenue
  • EYPT $45,713,000.00
  • GCBC $65,848,000.00
  • Revenue This Year
  • EYPT N/A
  • GCBC N/A
  • Revenue Next Year
  • EYPT N/A
  • GCBC N/A
  • P/E Ratio
  • EYPT N/A
  • GCBC $17.66
  • Revenue Growth
  • EYPT 7.50
  • GCBC N/A
  • 52 Week Low
  • EYPT $5.90
  • GCBC $25.25
  • 52 Week High
  • EYPT $29.31
  • GCBC $37.25
  • Technical
  • Relative Strength Index (RSI)
  • EYPT 36.22
  • GCBC 51.00
  • Support Level
  • EYPT $5.90
  • GCBC $27.07
  • Resistance Level
  • EYPT $6.67
  • GCBC $27.62
  • Average True Range (ATR)
  • EYPT 0.71
  • GCBC 0.71
  • MACD
  • EYPT -0.04
  • GCBC 0.16
  • Stochastic Oscillator
  • EYPT 8.99
  • GCBC 77.95

About EYPT EyePoint Pharmaceuticals Inc.

EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.

About GCBC Greene County Bancorp Inc.

Greene County Bancorp Inc is a holding firm. Its primary business involves overseeing and directing the business of The Bank of Greene County and monitoring its cash position. Through its directly and indirectly owned subsidiaries, the company engages in attracting retail deposits, along with funds generated from operations and borrowings, predominantly in one to four-family residential mortgage loans, commercial real estate mortgage loans, consumer loans, home equity loans, and commercial business loans. It also serves local municipalities' banking needs and operates a real estate investment trust.

Share on Social Networks: